{
    "clinical_study": {
        "@rank": "63793", 
        "arm_group": [
            {
                "arm_group_label": "Control", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Control group receive same volume of normal saline as in the magnesium group"
            }, 
            {
                "arm_group_label": "magnesium", 
                "arm_group_type": "Experimental", 
                "description": "This group receive magnesium sulfate perioperatively."
            }
        ], 
        "brief_summary": {
            "textblock": "The hypothesis of this study is that in staged bilateral total knee arthroplasty (TKA,\n      magnesium sulfate administered during the perioperative period of the first TKA may decrease\n      pain after the second TKA. It is known that pain is greater in the second TKA than in the\n      first. Therefore, we compared pain of the second TKA between the magnesium and control\n      groups."
        }, 
        "brief_title": "Magnesium and TKA Pain", 
        "condition": "Pain", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria: American society of anesthesiologist physical status 1 - 2. patients\n        scheduled to undergo staged bilateral TKA\n\n        Exclusion Criteria: American society of anesthesiologist physical status >3\n\n        -"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 13, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01945437", 
            "org_study_id": "Mg_TKA"
        }, 
        "intervention": {
            "arm_group_label": "magnesium", 
            "description": "The magnesium group receive intravenous magnesium sulfate.", 
            "intervention_name": "Magnesium Sulfate", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Magnesium Sulfate"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "September 13, 2013", 
        "number_of_arms": "2", 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "South Korea: Ministry of Food and Drug Safety"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Pain measured with visual analogue scale (VAS)", 
            "measure": "Pain", 
            "safety_issue": "No", 
            "time_frame": "from the end of the TKA until 48 hour"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01945437"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Seoul National University Bundang Hospital", 
            "investigator_full_name": "Kim Mihyun", 
            "investigator_title": "Doctor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "analgesic consumptions from the end of the TKA until 48 hours", 
            "measure": "analgesic", 
            "safety_issue": "No", 
            "time_frame": "from the end of the TKA until 48 hours"
        }, 
        "source": "Seoul National University Bundang Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Seoul National University Bundang Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}